BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Denali Therapeutics

Denali Therapeutics logo

Founded
2015
Geography
United States of America based
Funding
$347 M

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.


Posts Mentioning This Company

R&D Platform

Recent groundbreaking scientific insights into the genetic causes and biological processes underlying neurodegenerative diseases offer an unprecedented opportunity for the discovery and development of effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet